Browsed by
Month: March 2022

RMI Launches 2022 Champions of Maryland Manufacturing Program And Recognizes President Dr. Mike Galiazzo as 2022 Grand Champion

RMI Launches 2022 Champions of Maryland Manufacturing Program And Recognizes President Dr. Mike Galiazzo as 2022 Grand Champion

2022 Champions will be showcased online beginning March 30, 2022 and celebrated in person on November 17, 2022. Submit your Champion story today! The Regional Manufacturing Institute of Maryland (RMI) is excited to announce the launch of the “2022 Champions of Maryland Manufacturing” program. The Champions program highlights achievements in Maryland’s manufacturing eco-system to include Champions from business, education, government and the community. Champions are outstanding individuals, companies, organizations, and agencies whose exemplary efforts of manufacturing-related innovation, leadership, goodwill, growth and transformation deserve recognition. Champions inspire others through their remarkable stories of success. RMI will collect and showcase the stories online in its Champions of Maryland Manufacturing Directory. Those interested in submitting their own story or the story of an individual, company, organization, agency or academic institution whose extraordinary efforts deserve recognition can do so via this form. Additionally, on November 17, 2022, the Champions and the 2022 Grand Champion, Dr. Mike Galiazzo, RMI President, will be recognized at the Maryland Manufacturing Celebration at Martin’s West from 5-8:30 PM. Submit your story here  ...  Read more

QIAGEN reaches milestone with 100 million QuantiFERON tests used to detect TB

QIAGEN reaches milestone with 100 million QuantiFERON tests used to detect TB

HILDEN, Germany & GERMANTOWN, Md.–(BUSINESS WIRE)– QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today marked World TB Day by announcing its QuantiFERON blood test has been used to screen patients for tuberculosis (TB) infection more than 100 million times since its launch – an achievement that cements its status as the gold standard in the fight against this contagious and often deadly disease. ...  Read more

Emergent’s Recent Rebrand – A Symbol of Defense and Determination

Emergent’s Recent Rebrand – A Symbol of Defense and Determination

Emergent BioSolutions is no doubt one of the most widely-known biotechnology companies in the BioHealth Capital Region, with numerous locations in Gaithersburg, Baltimore, and beyond. If you’re a follower of Emergent, you’ve probably noticed a change in their corporate look and feel over the past few months. ...  Read more

U.S. Pharmacopeia Medicine Supply Map releases global API manufacturing findings

U.S. Pharmacopeia Medicine Supply Map releases global API manufacturing findings

Rockville, MD, March 16, 2022 – U.S. Pharmacopeia (USP), an independent scientific organization, announces the USP Medicine Supply Vulnerability Insights Series sourced from USP’s global Medicine Supply Map. The first of its kind, the USP Medicine Supply Map leverages insights derived from the use of USP quality standards in more than 22 thousand locations around the world, spanning 92 percent of generic medicines approved in the US. ...  Read more

Gain Therapeutics Presents Positive Data on its Structurally Targeted Allosteric Regulators in both Parkinson’s and Alzheimer’s Disease at the AD/PD 2022 Conference

Gain Therapeutics Presents Positive Data on its Structurally Targeted Allosteric Regulators in both Parkinson’s and Alzheimer’s Disease at the AD/PD 2022 Conference

BETHESDA, Md., March 15, 2022 (GLOBE NEWSWIRE) — Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”), a biotechnology company transforming the drug discovery paradigm with structurally targeted allosteric regulators (STARs) identified with its proprietary computational discovery platform, today presented new pre-clinical data from its Parkinson’s and Alzheimer’s Disease programs. These results were highlighted in a poster presentation at the International Conference on Alzheimer’s (AD) and Parkinson’s Diseases (PD) being held March 15 – 20, 2022 virtually and in Barcelona, Spain. The data shows that improvement of the lysosomal function through the enhancement of glucocerebrosidase (GCase) levels and activity can improve key pathological features in α-synucleinopathies and AD. ...  Read more

TEDCO Invests $100K in Pre-Seed Technology Start-up, The Black Brain Trust

TEDCO Invests $100K in Pre-Seed Technology Start-up, The Black Brain Trust

TEDCO, Maryland’s economic engine for technology companies, announced today its Builder Fund invested $100,000 in The Black Brain Trust, a DEI technology start-up based in Maryland. TEDCO’s Builder Fund invests in and provides executive support to Maryland-based technology companies run by entrepreneurs who demonstrate economic disadvantage. ...  Read more

Gaithersburg’s Salubris Biotherapeutics Announces $32 Million Financing to Advance Novel Complex Biologics for Cardiovascular, Oncology, and Neurodegenerative Diseases

Gaithersburg’s Salubris Biotherapeutics Announces $32 Million Financing to Advance Novel Complex Biologics for Cardiovascular, Oncology, and Neurodegenerative Diseases

– Reports Promising Early Data from Lead Clinical Program, JK07, for the Treatment of Heart Failure with Reduced Ejection Fraction – ...  Read more

Medical manufacturing investments help to increase healthcare supply chain resiliency

Medical manufacturing investments help to increase healthcare supply chain resiliency

Healthcare supply chain resiliency is on the rise in Maryland with the introduction of a new partnership between United Safety Technology, Inc. (UST) and Tradepoint Atlantic. Governor Larry Hogan recently announced the company’s plans for a new manufacturing facility located in Sparrows Point, aimed at producing critical medical supplies. ...  Read more